The October Genome Advance of the Month highlights a study, published in the Proceedings of the National Academy of Sciences, which demonstrates the advantages of whole genome sequencing versus whole exome sequencing in the identification of autosomal recessive retinitis pigmentosa - an inherited disease that ultimately leads to blindness.
Join us Friday, December 6th for our next Genomics in Medicine lecture, featuring Electron Kebebew, M.D., Chief of the Endocrine Oncology Branch, National Cancer Institute, NIH. His talk - Genetics and Genomics of Thyroid Neoplasms: Moving Closer Towards Personalized Patient Care - will reveal how genetic and genomic studies have improved our understanding o […]
Medicated adhesive patches have become a preferred method of delivery for everything from nicotine to hormones to motion sickness medication.Drexel University researchers are trying to expand the possibilities of this system--called transdermal delivery--with the help of a cleverly designed delivery vehicle and an ultrasonic "push," or pressure fro […]
Additive manufacturing, the technological innovation behind 3-D printing, has revolutionized the way we conceive of and build everything from electronic devices to jewelry to artificial organs. It is not surprising that this field has enjoyed enormous economic returns, which are projected to grow over the coming decade. According to a recent industry report […]
While 3-D pens and printers are enjoyed by students, artists and makers, innovative American companies are using similar equipment to manufacture aerospace, automotive and medical technologies. The number of technologies customized and created using additive manufacturing processes is growing each year. But understanding how the processes work takes more tha […]
Some babies diagnosed with and treated for a bone marrow failure disorder, called Diamond Blackfan Anemia, may actually be affected by a very rare anemia syndrome that has a different disease course and treatment, say scientists from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Steroid hormones and their metabolites within the central nervous system are commonly defined as neuroactive steroids or neurosteroids. Although neuroactive steroids have been shown to improve learning and memory ability and protect against amyloid beta peptide-induced neurotoxicity, changes in their level during Alzheimer's disease and their role in Aβ […]